VistaGen Therapeutics Inc
1.62 - 24.71
Join Discuss about VTGN with like-minded investors
RECAP 6/27 Unusual Calls $BITO Jun30 14 C $TQQQ Jul08 35 C $DISH Jul08 20 C $HOOD Jul01 9 C $EWG Jul 24.75 C $ASHR Jul 35 C $LAZR Aug 10 C $C Sep 55/62.5 C Spd $RBLX Oct 75 C $CRK Jul 15 C $VAL Aug 50/60 C Spd $MRK Jul01 96 C $CHPT Jul08 16/19 C Spd $SABR Aug 8 C $DAL Aug 35 C $WOW Aug 17.5 C $VTGN Aug 1/2.5 C Spd $DNA Aug 3.5 C $HOOD Jan 20 C $FXI Jul 35 C $KRE Dec 73 C
129 Replies 8 👍 6 🔥
Next Dividend Date
we have developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into mature, non-transformed, human cells which can be used to create novel bioassay systems for predictive toxicology, drug metabolism screening, drug discovery, drug rescue and cell therapy. we believe our stem cell technology platform, human clinical trials in a test tube™, can provide clinically relevant predictions of potential toxicity and metabolism issues of promising new drug candidates long before they are ever tested in humans.